{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:03:21Z","timestamp":1790485401417,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T00:00:00Z","timestamp":1261440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T00:00:00Z","timestamp":1261440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1245\/s10434-009-0865-y","type":"journal-article","created":{"date-parts":[[2009,12,21]],"date-time":"2009-12-21T16:27:54Z","timestamp":1261412874000},"page":"967-972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer"],"prefix":"10.1245","volume":"17","author":[{"given":"Norikatsu","family":"Miyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshi","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Hitora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Tei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsugu","family":"Sekimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,22]]},"reference":[{"key":"865_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.cgt.7701070","volume":"14","author":"SI Kohno","year":"2007","unstructured":"Kohno SI, Luo C, Nawa A, et al. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus. Cancer Gene Ther. 2007;14:918\u201326.","journal-title":"Cancer Gene Ther"},{"key":"865_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/annurev.bi.49.070180.002505","volume":"49","author":"JE Folk","year":"1980","unstructured":"Folk JE. Transglutaminases. Annu Rev Biochem. 1980;49:517\u201331.","journal-title":"Annu Rev Biochem"},{"key":"865_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrm1014","volume":"4","author":"L Lorand","year":"2003","unstructured":"Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol. 2003;4:140\u201356.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"865_CR4","doi-asserted-by":"publisher","first-page":"33582","DOI":"10.1074\/jbc.M105318200","volume":"276","author":"MA Antonyak","year":"2001","unstructured":"Antonyak MA, Singh US, Lee DA, et al. Effects of tissue transglutaminase on retinoic acid\u2013induced cellular differentiation and protection against apoptosis. J Biol Chem. 2001;276:33582\u20137.","journal-title":"J Biol Chem"},{"key":"865_CR5","doi-asserted-by":"publisher","first-page":"20127","DOI":"10.1074\/jbc.C200147200","volume":"277","author":"JE Boehm","year":"2002","unstructured":"Boehm JE, Singh U, Combs C, et al. Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem. 2002;277:20127\u201330.","journal-title":"J Biol Chem"},{"key":"865_CR6","doi-asserted-by":"publisher","first-page":"41461","DOI":"10.1074\/jbc.M404976200","volume":"279","author":"MA Antonyak","year":"2004","unstructured":"Antonyak MA, Miller AM, Jansen JM, et al. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem. 2004;279:41461\u20137.","journal-title":"J Biol Chem"},{"key":"865_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000084237","volume":"38","author":"LS Mangala","year":"2005","unstructured":"Mangala LS, Mehta K. Tissue transglutaminase (TG2) in cancer biology. Prog Exp Tumor Res. 2005;38:125\u201338.","journal-title":"Prog Exp Tumor Res"},{"key":"865_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000084229","volume":"38","author":"K Mehta","year":"2005","unstructured":"Mehta K. Mammalian transglutaminases: a family portrait. Prog Exp Tumor Res. 2005;38:1\u201318.","journal-title":"Prog Exp Tumor Res"},{"key":"865_CR9","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1158\/0008-5472.CAN-06-1457","volume":"66","author":"AP Mann","year":"2006","unstructured":"Mann AP, Verma A, Sethi G, et al. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res. 2006;66:8788\u201395.","journal-title":"Cancer Res"},{"key":"865_CR10","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","volume":"80","author":"LH Sobin","year":"1997","unstructured":"Sobin LH, Fleming ID. TNM classification of malignant tumors, 5th edn. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer. 1997;80:1803\u20134.","journal-title":"Cancer"},{"key":"865_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/bjc.1997.420","volume":"76","author":"K Mimori","year":"1997","unstructured":"Mimori K, Mori M, Shiraishi T, et al. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer. 1997;76:531\u20136.","journal-title":"Br J Cancer"},{"key":"865_CR12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0016-5085(93)90900-W","volume":"105","author":"M Mori","year":"1993","unstructured":"Mori M, Staniunas RJ, Barnard GF, et al. The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology. 1993;105:820\u20136.","journal-title":"Gastroenterology"},{"key":"865_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0968-0004(02)02182-5","volume":"27","author":"L Fesus","year":"2002","unstructured":"Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci. 2002;27:534\u20139.","journal-title":"Trends Biochem Sci"},{"key":"865_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ijc.2910580316","volume":"58","author":"K Mehta","year":"1994","unstructured":"Mehta K. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer. 1994;58:400\u20136.","journal-title":"Int J Cancer"},{"key":"865_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jcp.20014","volume":"200","author":"JS Chen","year":"2004","unstructured":"Chen JS, Konopleva M, Andreeff M, et al. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol. 2004;200:223\u201334.","journal-title":"J Cell Physiol"},{"key":"865_CR16","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.1158\/1078-0432.CCR-04-1107","volume":"10","author":"K Mehta","year":"2004","unstructured":"Mehta K, Fok J, Miller FR, et al. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res. 2004;10:8068\u201376.","journal-title":"Clin Cancer Res"},{"key":"865_CR17","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/sj.onc.1209324","volume":"25","author":"JF Herman","year":"2006","unstructured":"Herman JF, Mangala LS, Mehta K. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene. 2006;25:3049\u201358.","journal-title":"Oncogene"},{"key":"865_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/hep.20812","volume":"42","author":"Z Sarang","year":"2005","unstructured":"Sarang Z, Molnar P, Nemeth T, et al. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice. Hepatology. 2005;42:578\u201387.","journal-title":"Hepatology"},{"key":"865_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1055\/s-0038-1642451","volume":"71","author":"D Aeschlimann","year":"1994","unstructured":"Aeschlimann D, Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb Haemost. 1994;71:402\u201315.","journal-title":"Thromb Haemost"},{"key":"865_CR20","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1074\/jbc.273.6.3452","volume":"273","author":"D Aeschlimann","year":"1998","unstructured":"Aeschlimann D, Koeller MK, Allen-Hoffmann BL, Mosher DF. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. Detection and identification of transglutaminase gene products based on reverse transcription\u2013polymerase chain reaction with degenerate primers. J Biol Chem. 1998;273:3452\u201360.","journal-title":"J Biol Chem"},{"key":"865_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1357-2725(99)00045-X","volume":"31","author":"JS Chen","year":"1999","unstructured":"Chen JS, Mehta K. Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol. 1999;31:817\u201336.","journal-title":"Int J Biochem Cell Biol"},{"key":"865_CR22","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1096\/fasebj.5.15.1683845","volume":"5","author":"CS Greenberg","year":"1991","unstructured":"Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991;5:3071\u20137.","journal-title":"FASEB J"},{"key":"865_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/carcin\/bgm280","volume":"29","author":"L Ai","year":"2008","unstructured":"Ai L, Kim WJ, Demircan B, et al. The transglutaminase 2 gene (TGM2.), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis. 2008;29:510\u20138.","journal-title":"Carcinogenesis"},{"key":"865_CR24","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1200\/JCO.2007.12.2234","volume":"25","author":"T Andre","year":"2007","unstructured":"Andre T, Quinaux E, Louvet C, et al. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1. J Clin Oncol. 2007;25:3732\u20138.","journal-title":"J Clin Oncol"},{"key":"865_CR25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1053\/j.gastro.2008.02.098","volume":"134","author":"BM Wolpin","year":"2008","unstructured":"Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134:1296\u201310.","journal-title":"Gastroenterology"},{"key":"865_CR26","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ejso.2008.01.019","volume":"34","author":"M Kornmann","year":"2008","unstructured":"Kornmann M, Formentini A, Ette C, et al. Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol. 2008;34:1316\u201321.","journal-title":"Eur J Surg Oncol"},{"key":"865_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2407-4-32","volume":"4","author":"OF Bathe","year":"2004","unstructured":"Bathe OF, Dowden S, Sutherland F, et al. 2004 Phase II study of neoadjuvant 5-FU\u00a0+\u00a0leucovorin\u00a0+\u00a0CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer. 4:32.","journal-title":"BMC Cancer"},{"key":"865_CR28","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(02)09290-5","volume":"359","author":"AM Lacy","year":"2002","unstructured":"Lacy AM, Garcia-Valdecasas JC, Delgado S, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359:2224\u20139.","journal-title":"Lancet"},{"key":"865_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.287.3.321","volume":"287","author":"JC Weeks","year":"2002","unstructured":"Weeks JC, Nelson H, Gelber S, et al. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002;287:321\u20138.","journal-title":"JAMA"},{"key":"865_CR30","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1056\/NEJMoa032651","volume":"350","author":"Group COoSTS","year":"2004","unstructured":"Group COoSTS. 2004 A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 350:2050\u20139.","journal-title":"N Engl J Med"},{"key":"865_CR31","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2006.09.7758","volume":"25","author":"DG Jayne","year":"2007","unstructured":"Jayne DG, Guillou PJ, Thorpe H, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25:3061\u20138.","journal-title":"J Clin Oncol"},{"key":"865_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s004320050247","volume":"125","author":"JA Han","year":"1999","unstructured":"Han JA, Park SC. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line. J Cancer Res Clin Oncol. 1999;125:89\u201395.","journal-title":"J Cancer Res Clin Oncol"},{"key":"865_CR33","first-page":"913","volume":"20","author":"E Devarajan","year":"2002","unstructured":"Devarajan E, Chen J, Multani AS, et al. Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features. Int J Oncol. 2002;20:913\u201320.","journal-title":"Int J Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-009-0865-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0865-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-009-0865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T11:03:11Z","timestamp":1735210991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-009-0865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,22]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1245\/s10434-009-0865-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,22]]},"assertion":[{"value":"20 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2009","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}